来利Larlly品牌怎么样 申请店铺

我要投票 来利Larlly在减肥药行业中的票数:679 更新时间:2025-08-03
来利Larlly,专业减肥药品牌,安全、健康品牌。 浙江海正药业股份有限公司,创建于1956年,为国有控股上市公司,总部位于浙江省台州市,现有员工9000多人,2000年7月“海正药业”A股在上海证券

外推网助力来利Larlly品牌出海!将品牌入驻外推网,定制来利Larlly品牌推广信息,可以显著提高来利Larlly产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

来利Larlly怎么样

来利Larlly,专业减肥药品牌,安全、健康品牌。

浙江海正药业股份有限公司,创建于1956年,为国有控股上市公司,总部位于浙江省台州市,现有员工9000多人,2000年7月“海正药业”A股在上海证券交易所上市(股票代码:600267)。海正先后获得“国家高新技术企业”、国家首批“创新型企业”、“技术创新示范企业”、“国家知识产权试点企业”、“药品出口示范基地”、全国五一劳动奖状等称号,还多次荣获“出口型企业品牌十强”、“创新型企业品牌十强”和“全国制造业500强”。2014年,荣登财富中国500强排行榜入围浙江省首批“三名”企业名单。“海正”、“HISUN”和被认定为驰名保护,并圆满完成了“抗甲流药物达菲关键中间体——环氧化物生产”国家任务,受到国务院和有关部委的表扬、省政府的单独表彰。

海正在浙江台州、杭州以及江苏如东等地区建有一体化制药基地,主营抗肿瘤、抗感染、心血管、内分泌、免疫抑制、抗抑郁、骨科等领域的原料药、制剂的研产销业务,业务遍及全球70多个国家和地区。2014年,海正药业销售收入超过100亿元。

海正建有国家认定的企业技术中心和博士后科研工作站,在北京、上海等地分别建有研发机构。每年研发投入占工业销售收入8%以上,研发人员近1200人,其中国家“千人计划”8人,省“千人计划”19人,形成了以国内科学家为主体,欧美、日本、俄罗斯等国的多名国外科学家组成的基因工程药物、微生物药物、合成药物、制剂、新药筛选等领域的科研创新人才团队。同时,围绕“生物药、化学药”两大领域开展自主品牌新药创制,与国内30所大学、研究院所产学研结合,联盟化发展,在特色原料药产业化和高端制剂产业化等形成了特色和优势。

海正积极推进民族医药创新和国际化进程,实施“五大转型”,不断推进原料制剂一体化、制剂品牌化和生物产业化,已从单纯的产品出口、贸易伙伴发展成为与国际大公司建立战略联盟,从单一的原料药出口发展为原料药与自主品牌制剂同步,从为国外大公司定制生产发展为共同创新研发。



Larlly, a professional weight-loss drug brand, is a safe and healthy brand. Zhejiang Haizheng Pharmaceutical Co., Ltd., founded in 1956, is a state-owned holding listed company with its headquarters in Taizhou City, Zhejiang Province. It has more than 9000 employees. In July 2000, "Haizheng pharmaceutical" a share was listed on the Shanghai Stock Exchange (Stock Code: 600267). Haizheng has successively won the titles of "national high and new technology enterprise", the first batch of "innovative enterprise", "technological innovation demonstration enterprise", "national intellectual property pilot enterprise", "drug export demonstration base", National May 1st Labor Medal, etc., and has also won "top 10 export-oriented enterprise brands", "top 10 innovative enterprise brands" and "top 500 national manufacturing industry" for many times. In 2014, it was listed as one of the first "three" enterprises in Zhejiang Province. "Haizheng" and "Hisun" have been recognized as well-known protection, and successfully completed the national task of "production of epoxide, a key intermediate of Tamiflu, an anti H1N1 drug", which has been praised by the State Council and relevant ministries and commissions, as well as the provincial government. Haizheng is building an integrated pharmaceutical base in Taizhou, Hangzhou, Zhejiang Province and Rudong, Jiangsu Province. It is mainly engaged in the research, production and marketing of raw materials and preparations in the fields of anti-tumor, anti infection, cardiovascular, endocrine, immunosuppression, anti depression, orthopedics, etc. its business covers more than 70 countries and regions in the world. In 2014, the sales revenue of Haizheng pharmaceutical exceeded 10 billion yuan. Haizheng has established enterprise technology centers and postdoctoral research stations recognized by the state, and R & D institutions in Beijing, Shanghai and other places. The annual R & D investment accounts for more than 8% of the industrial sales revenue, with nearly 1200 R & D personnel, including 8 in the national "thousand talents plan" and 19 in the provincial "thousand talents plan", forming a scientific research innovator in the fields of genetic engineering drugs, microbial drugs, synthetic drugs, preparations, new drug screening, etc., mainly composed of domestic scientists and many foreign scientists from Europe, America, Japan, Russia and other countries Only team. At the same time, the independent brand new drug creation is carried out around the two major fields of "biological medicine and chemical medicine", combined with the production, teaching and research of 30 universities and research institutes in China, and developed in alliance, forming features and advantages in the industrialization of characteristic APIs and high-end preparations. Haizheng has actively promoted the innovation and internationalization of national medicine, implemented the "five transformations", and continuously promoted the integration of raw materials and preparations, the branding of preparations and the bio industrialization. It has developed from a simple product export and trade partner to a strategic alliance with large international companies. It has developed from a single raw material drug export to a raw material drug and an independent brand preparation. It has developed from a single raw material drug export to a foreign company The development of manufacturing and production is joint innovation and R & D.

本文链接: https://brand.waitui.com/91230fb32.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美国亚利桑那州特大火灾级别山火肆虐 仅11%火势被控制

据央视新闻援引美国媒体报道,截至当地时间8月2日,亚利桑那州大峡谷国家公园北缘景区的山火过火面积已超过454平方公里,仅11%的火势得到控制。报道称,干燥的天气状况影响了火势的控制,预计山火所处地区直到下周中期才可能会迎来降水。这场山火于1日达到特大火灾级别,是美国本土当时在燃的最大山火,并成为亚利桑那州有记录以来最大规模的十大火灾之一。该山火已摧毁了历史悠久的“大峡谷旅馆”和至少70座建筑物。

40分钟前

上半年南京信息传输、软件和信息技术服务业增加值增长5.9%

上半年,南京信息传输、软件和信息技术服务业增加值增长5.9%。南京软件产业规模从2005年的166亿元增长至2024年的8600亿元,位列江苏省第一、全国前列。(证券时报)

40分钟前

广东发布《广东省中小企业数字化转型金融服务工作方案》

8月3日,中国人民银行广东省分行会同广东省工业和信息化厅联合印发《广东省中小企业数字化转型金融服务工作方案》(简称《工作方案》)。《工作方案》具体部署了四个方面、十五项工作措施。一是强化中小企业数字化转型金融支持。二是提升数字化转型金融服务的专业化能力。加快推动金融业数字化智能化转型,建立数字化转型融资对接机制,强化数据要素赋能金融服务,完善数字化转型融资的风险分担机制。三是提升重点领域数字化转型金融服务质效。四是强化工作组织实施。

40分钟前

首个机器人消费节启动,线上线下买机器人最高可获1500元补贴

8月2日,北京经开区启动全球首个以机器人消费为主题的节日——E-Town机器人消费节。本届消费节将于8月2日至17日在北人亦创国际会展中心、机器人大世界及龙湖北京亦庄天街、大族广场等六大商圈同步展开。北京经开区将发放专属消费券,个人消费者购买机器人产品最高可获得1500元补贴。(证券时报)

40分钟前

山西:25条措施力促能源领域民营经济发展

8月3日,山西省能源局、省民营经济发展局联合制定了《促进全省能源领域民营经济发展若干措施》,共25条,以引导民营经济在推进全省能源绿色低碳转型和加快构建具有山西特色的新型能源体系中做大做优做强。具体措施包括:支持民营企业参与充电基础设施、智能微电网建设,支持民营企业控股或参股建设增量配电网试点;支持民营企业通过参股方式积极参与投资建设非干线管道等天然气基础设施;支持民营企业参与山西省风光基地、年度风光项目竞争性配置,鼓励国有企业配置不低于10%的项目股权吸引民营企业参股;支持民营企业参与晋北采煤沉陷区新能源基地项目等国家大型风光基地设备供应及投资建设等。

40分钟前

本页详细列出关于来利Larlly的品牌信息,含品牌所属公司介绍,来利Larlly所处行业的品牌地位及优势。
咨询